Compounds from wild mushrooms with antitumor potential

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 5, 2010, Pages 424-436

  Ferreira, Isabel C F R ^a   Vaz, Josiana A ^a,b   Vasconcelos, M Helena ^b   Martins, Anabela ^a  

^a INSTITUTO POLITÉCNICO DE BRAGANÇA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antitumor; High molecular weight compounds; Low molecular weight compounds; Mushrooms

Indexed keywords

AMINE; ANTINEOPLASTIC AGENT; CATECHOL DERIVATIVE; CEREBROSIDE; CYCLOEPOXYDON; ERGOSTEROL; GENISTEIN; GERMANIUM DERIVATIVE; GLUCAN; GLYCAN DERIVATIVE; GLYCOPEPTIDE; GLYCOPROTEIN; HISPIDIN; ILLUDIN M; ILLUDIN S; ISOFLAVONE DERIVATIVE; LUCIDENIC ACID O; LUCIDENIC LACTONE; LUCIDUMOL A; LUCIDUMOL B; NATURAL PRODUCT; PANEPOXYDONE; PROTEOGLYCAN; PUTRESCINE 1,4 DICINNAMIDE; QUINONE DERIVATIVE; SELENIUM DERIVATIVE; SESQUITERPENE DERIVATIVE; STEROID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ISOLATION; FUNCTIONAL FOOD; HUMAN; MOLECULAR WEIGHT; MUSHROOM; NONHUMAN; ORIENTAL MEDICINE; STRUCTURE ACTIVITY RELATION; TRADITIONAL MEDICINE; TUMOR GROWTH;

EID: 77953764513     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871520611009050424     Document Type: Article

References (73)

1. Siro, I.; Kapolna, E.; Kapolna, B.; Lugasi, A. Functional food. Product development, marketing and consumer acceptance-A review. Appetite, 2008, 51, 456-467.
2. Hasler, C.M. Functional foods: their role in disease prevention and health promotion. Food Technol., 1998, 52, 63-70.
3. Andlauer, W.; Furst, P. Nutraceuticals: a piece of history, present status and outlook. Food Res. Int., 2002, 35, 171-176.
4. Baker, J.T.; Borris, R.P.; Carte, B.; Cardell, G.A.; Soejarto, D.D.; Gragg, G.M.; Gupta, M.P.; Iwn, M.M.; Madulid, D.R.; Tyler, V.E. Natural product drug discovery and development: new perspective on international collaboration. J. Nat. Prod., 1995, 58, 1325-1357.
5. Donadio, S.; Monciardini, P.; Alduina, R.; Mazza, P.; Chiocchini, C.; Cavaletti, L.; Sosio, M.; Puglia, A.M. Microbial technologies for the discovery of novel bioactive metabolites. J. Biotechnol., 2002, 99, 187-198.
6. Mizuno, T. Bioactive biomolecules of mushrooms: Food function and medicinal effect of mushroom fungi. Food Rev. Int., 1995, 11, 7-21.
7. Wasser, S.P. New and noteworthy species of the genus Agaricus L.: Fr. emend. Karst. from Israel. Documents Mycologiques, 1995, 25, (98-100), 469-478.
8. Wasser, S.P. Medicinal mushrooms as a source of antitumor and immunomodulatory polysaccharides. Appl. Microbiol. Biotechnol., 2002, 60, 258-274.
9. Wasser, S.P.; Weis, A. Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int. J. Med. Mushrooms, 1999, 1, 31-62.
10. Hawksworth, D.L. Mushrooms: the extent of the unexplored potential. Int. J. Med. Mushrooms, 2001, 3, 333-337.
11. Liu, F.; Ooi, V.; Chang, S.T. Antitumor components of the culture filtrates from Tricholoma sp. J. Microbiol. Biotechnol., 1995, 11, 486-490.
12. Zaidman, B.; Yassin, M.; Mahajana, J.; Wasser, S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl. Microbiol. Biotechnol., 2005, 67, 453-468.
13. Poucheret, P.; Fons, F.; Rapior, S. Biological and pharmacological activity of higher fungi: 20-year retrospective analysis. Mycologie, 2006, 27, 311-333.
14. Pujol, V.; Seux, V.; Villard, J. Research of antifungal substances secreted by higher fungi in culture. Ann. Pharm. Fr., 1990, 48, 17-22.
15. Clericuzio, M.; Piovano, M.; Chamy, M.C.; Garbarino, J.A.; Milanesio, M.; Viterbo, D.; Vidari, G.; Vita; Finzi, P. Structural characterization of metabolites from Pholiota spumosa (Basidiomycestes). Croat. Chem. Acta, 2004, 77, 605-611.
16. Ooi, V.E.; Liu, F. Immunomodulation and anticancer activity of polysaccharide-protein complexes. Curr. Med. Chem., 2000, 7, 715-729.
17. Ajith, T.A.; Janardhanan, K.K. Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J. Clin. Biochem. Nutr., 2007, 40, 157-162.
18. Wasser, S.P.; Weis, A.L. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit. Rev. Immunol., 1999, 19, 65-96.
19. Lindequist, U.; Niedermeyer, T.H.J.; Julich W.-D. The Pharmacological potential of mushrooms. eCAM, 2005, 2, 285-299.
20. Kellof, G.J.; Sigman, C.C. Intervention and Chemoprevention of Cancer. CCS Associates, Mountain View, CA, USA, 2000.
21. Borchers, A.; Keen, C.L.; Gershwin, M.E. Mushrooms, tumors, and immunity: an update. Exp. Biol. Med., 2004, 229, 393-406.
22. Haak-Frendscho, M.; Kino, K.; Sone, T.; Jardieu, P. Ling Zhi-8: a novel T cell mitogen induces cytokine production and upregulation of ICAM-1 expression. Cell. Immunol., 1993, 150, 101-113.
23. Gan, K.H.; Fann, Y.F.; Hsu, S.H.; Kuo, K.W.; Lin, C.N. Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. J. Nat. Prod., 1998, 61, 485-487.
24. Eo, S.K.; Kim, Y.S.; Lee, C.K.; Han, S.S. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J. Ethnopharmacol., 1999, 68, 129-136.
25. Mattila, P.; Suonpää, K.; Piironen, V. Functional properties of edible mushrooms. Nutrition, 2000, 16, 694-696.
26. Hatvani, N. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int. J. Antimicrob. Agents, 2001, 17, 71-74.
27. Bose, S.R. Campestrin, the antibiotic of Psalliota campestris. Nature, 1955, 175, 468-472.
28. Hikino, H.; Ishiyama, M.; Suzuki, Y.; Konno, C. Isolation and hypoglicemic activity of ganoderan A and B, glycans of Ganoderma lucidium fruit bodies. Planta Med., 1985, 54, 339-343.
29. Harttig, U.; Anke, T.; Scherer, A.; Steglich, W. Leaianafulvene, a sesquiperpenoid fulvene derivative from cultures of Mycena leaiana. Phytochemistry, 1990, 29, 3942-3944.
30. Sarkar, S.; Koga, J.; Whitley, R.J.; Chatterjee, S. Antiviral effect of the extract of cultured medium of Lentinus edodes mycelia on the replication of Herpes simplex virus type I. Antiviral Res., 1993, 20, 293-303.
31. Cui, J.; Chisti, Y. Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol. Adv., 2003, 21, 109-110.
32. Cheung, L.M.; Cheung, P.C.K.; Ooi, V.E.C. Antioxidant activity and total phenolics of edible mushroom extracts. Food Chem., 2003, 81, 249-255.
33. Paterson, R.R.M. Ganoderma- a therapeutic funfal biofactor. Phytochemistry, 2006, 67, 1985-2001.
34. Cassinelli, G.; Lanzi, C.; Pensa, T.; Gambetta, R.A.; Nasini, G.; Cuccuru, G.; Cassinis, M.; Pratesi, G.; Polizzi, D.; Tortoreto, M.; Zunino, F. Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin. Biochem. Pharmacol., 2000, 59, 1539-1547.
35. Merlini, L.; Nasini, G.; Saglioni, L.; Cassinelli, G.; Lanzi, C. Structure elucidation of clavilactone D: an inhibitor of protein tyrosine kinases. Phytochemistry, 2000, 53, 1039-1041.
36. Tiffany, S.M.; Graham, D.G.; Vogel, F.S.; Cass, M.W.; Jeffs, P.W. Investigation of structure-function relationships of cytotoxic quinines of natural and synthetic origin. Cancer Res., 1978, 38, 3230-3235.
37. Kawagishi, H.; Hamajima, K.; Inoue, Y. Novel hydroquinone as a matrix metallo-proteinase inhibitor from the mushroom Piptoporus betulinus. Biosci. Biotechnol. Biochem. 2002, 66, 2748-2750.
38. Chang, K.L.; Kung, M.L.; Chow, N.H.; Su, S.J. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem. Pharmacol., 2004, 67, 717-726.
39. Choi, Y.H.; Lee, W.H.; Park, K.Y.; Zhang, L. p53-Independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res., 2000, 91, 164-173.
40. Gonindard, C.; Bergonzi, C.; Denier, C.; Sergheraert, C.; Klaebe, A.; Chavant, L.; Hollande, E. Synthetic hispidin, a PKC inhibitor, is more cytotoxic toward cancer cells than normal cells in vitro. Cell Biol. Toxicol., 1997, 13, 141-153.
41. Kim, D.S.; Jeong, H.J.; Bhat, K.P.; Park, S.Y.; Kang, S.H.; Yoo, E.H.; Lee, M.; Lee, H.W.; Krueger, R.J. Aromatse and sulfatase inhibitors from Lepiota americana. Planta Med., 2000, 66, 78-79.
42. Bok, J.W.; Lermer, L.; Chilton, J.; Klingeman, H.G.; Towers, G.H.N. Antitumor sterols from the mycelia of Cordyceps sinensis. Phytochemistry, 1999, 51, 891-898.
43. Silberborth, S.; Stumpf, A.; Erkel, G.; Anke, T.; Sterner, O. Gerronemins A-F, cytotoxic biscatechols from a Gerronema species. Phytochemistry, 2002, 59, 643-648.
44. Zhang, Y.; Mills, G.L.; Nair, M.G. Cyclooxygenase inhibitory and antioxidant compounds from the mycelia of the edible mushroom Grifola frondosa. J. Agric. Food Chem., 2002, 50, 7581-7585.
45. Can, K.-H.; Kuo, S.H.; Lin, C.-N. Steroidal constituents of Ganoderma applanatum and Ganoderma neo-japonicum. J. Nat. Prod., 1998, 61, 1421-1422.
46. Takaku, T.; Kimura, Y.; Okuda, H. Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J. Nutr., 2001, 131, 1409-1413.
47. Russo, A.; Piovano, M.; Clericuzio, M.; Lombardo, L.; Tabasso, S.; Chamy, M.C.; Vidari, G.; Cardile, V.; Vita-Finzi, P.; Garbarino, J.A. Putrescine-1,4 dicinnamide from Pholiota spumosa (Basidiomycetes) inhibits cell growth and induces cell death in human prostate carcinoma DU-145 cells. Phytomedicine, 2007, 14, 185-191.
48. Moradali, M.-F.; Mostafavi, H.; Ghods, S.; Hedjaroude, G.-A. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int. Immunopharmacol., 2007, 7(6), 701-724.
49. Mizushina, Y.; Takahashi, N.; Hanashima, L.; Koshino, H.; Esumi, Y.; Uzawa, J.; Sugawara, F.; Sakaguchi, K. Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete. Ganoderma lucidum. Bioorg. Med. Chem., 1999, 7, 2047-2052.
50. Jiang, J.; Grieb, B.; Thyagarajan, A.; Sliva, D. Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF kappaB signaling. J. Mol. Med., 2008, 21, 577-584.
51. Li, C.-H.; Chen, P.-Y.; Chang, U.-M.; Kan, L.-S.; Fang, W.-H.; Tsai, K.-S.; Lin, S.-B. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci., 2005, 77, 252-265.
52. Tang, W.; Liu, J.-W.; Zhao, W.-M.; Wei, D.-Z.; Zhong, J.-J. Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci., 2006, 80, 205-211.
53. Chiu, S.W.; Wang, Z.M.; Leung, T.M.; Moore, D. Nutritional value of Ganoderma extract and assessment of its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. Food Chem. Toxicol., 2000, 38 173-178.
54. Larone, D.H. Medically Important Fungi, 4th ed.; American Society for Microbiology: USA, 2002.
55. Zjawiony, J.K. Biologically active compounds from Aphyllophorales (Polypore) fungi. J. Nat. Prod., 2004, 67, 300-310.
56. Zhang, M.; Cui, S.W.; Cheung, P.C.K.; Wang, Q. Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity. Trend Food Sci. Technol., 2007, 18, 4-19.
57. Sternberg, S.S.; Philips, F.S.; Cronin, A.P.; Sodergren, J.E.; Vidal, P.M. Toxicological studies of calvacin. Cancer Res., 1963, 23, 1035-1048.
58. Wasser, S.P.; Weis, A.L. American Botanical Council, HerbClip™, HC 042319-224, 2003.
59. Quang, D.N.; Hashimoto, T.; Asakawa, Y. Inedible mushrooms: a good source of biologically active substances. Chem. Rec., 2006, 6, 79-99.
60. Israilides, C.; Kletsas, D.; Arapoglou, D.; Philippoussis, A.; Pratsinis, H.; Ebringerová, A.; Hribalová, V.; Harding, S.E. In vitro cytostatic and immunomodulatory properties of the medicinal mushroom Lentinula edodes. Phytomedicine, 2008, 15, 512-519.
61. Watanabe, T.; Ogawa, K. J. Study on preoperative intratumor administration of lentinan fopr gastric cancer cases. II Antitumor immune response of regional lymph nodes. Jpn. Soc. Cancer Ther., 1995, 30, 948-55.
62. Taguchi, T. Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer. Gan To Kagaku Ryoho, 1983, 10, 387-93.
63. Tari, K.; Satake, I.; Nakagomi, K.; Ozawa, K.; Oowada, F.; Higashi, Y.; Negishi, T.; Yamada, T. Effect of lentinan for advanced prostate carcinoma. Hinyokika Kiyo, 1994, 40, 119-23.
64. Bobek, P.; Galbavy, S. Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine- induced precancerous lesions in rat colon. Br. J. Biomed. Sci., 2001, 58, 164-168.
65. Zhuang, C.; Wasser, S.P. Medicinal value of culinary-medicinal Maitake mushroom Grifola frondosa (Dicks.:Fr.) S. F. Gray (Aphyllophoromycetideae). Review. Int. J. Med. Mushrooms, 2004, 6, 287-314.
66. Mizuno, T. Medicinal properties and clinical effects of culinarymedicinal mushroom Agaricus blazei Murrill. (Agaricomycetidae) (Review). Int. J. Med. Mushrooms, 2002, 4, 299-312.
67. Liu, F.; Fung, M.C.; Ooi, V.E.C.; Chang, S.T. in the mouse of gene expression of immunomodulating cytokines by mushroom polysaccharide-protein complexes. Life Sci., 1996, 58, 1795-1803.
68. Kidd, P.M. The use of mushroom glucans and proteoglycans in cancer treatment. Altern. Med. Rev., 2000, 5, 4-26.
69. Zhu, T.; Kim, S.-H.; Chen, C.-Y. A Medicinal mushroom: Phellinus linteus. Curr. Med. Chem., 2008, 15, 1330-1335.
70. Zhou, S.; Peng, J.F.; Chang, N.; Zhang, H.X.; Gong, F.; Zhang, C.K. Purification and crystallization of flammulin, a basic protein with anti-tumor activities from Flammulina velutipes. Chin. Chem. Lett., 2003, 14, 713-716.
71. Wang, H.; Ng, T.B.; Ooi, V.E. Lectins from mushrooms - a review. Mycol. Res., 1998, 102, 897-906.
72. Brzin, J.; Rogelj, B.; Popovic, T.; Strukelj, B.; Ritonja, A. Clitocypin, a new type of cysteine proteinase inhibitor from fruit bodies of mushroom Clitocybe nebularis. J. Biol. Chem., 2000, 275, 20104-20109.
73. Galesa, K.; Thomas, R.M.; Kidrica, M.; Pain, R.H. Clitocypin, a new cysteine proteinase inhibitor, is monomeric: impact on the mechanism of folding. Biochem. Biophys. Res. Commun., 2004, 324, 576-578.